Shenzhen Shenxin Biotechnology Co.
Latest round
- Series B
Last raised
- Mar 2022
Total raised
- $120M
Investors
- 12
About Shenzhen Shenxin Biotechnology Co.
, Ltd. is a biotechnology company that focuses on research and development of core mRNA delivery technology. The company has set up biotech R&D labs in Shenzhen, Nanjing and Hong Kong. Dr. Linxian Li, the company's founder and CEO, holds a PhD from the University of Heidelberg, Germany, was a postdoctoral fellow at MIT, and is currently an assistant professor at Karolinska School of Medicine. The company has an R&D and CMC team of nearly 200 people and a 4500 square meter R&D lab. The company is engaged in the development of novel preventive and therapeutic vaccines and drugs based on mRNA technology and LNP delivery technology. The company has four major R&D pipelines include infectious disease vaccines, rare diseases, therapeutic oncology vaccines, and oncology immunotherapy boosters.
Who invested in Shenzhen Shenxin Biotechnology Co.
12 investors across 3 rounds
See all investors in Shenzhen Shenxin Biotechnology Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Shenzhen Shenxin Biotechnology Co.
Who invested in Shenzhen Shenxin Biotechnology Co.?
Shenzhen Shenxin Biotechnology Co. has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Shenzhen Shenxin Biotechnology Co. raised?
Shenzhen Shenxin Biotechnology Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Shenzhen Shenxin Biotechnology Co. last raise money?
Shenzhen Shenxin Biotechnology Co.'s most recent round on record is a Series B, in Mar 2022.
What does Shenzhen Shenxin Biotechnology Co. do?
Shenzhen Shenxin Biotechnology Co. is a biotechnology company.
Where is Shenzhen Shenxin Biotechnology Co. headquartered?
Shenzhen Shenxin Biotechnology Co. is headquartered in Shenzhen, China.
Which VCs invest in companies like Shenzhen Shenxin Biotechnology Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Shenzhen Shenxin Biotechnology Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Shenzhen Shenxin Biotechnology Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.